Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02475850
Other study ID # U01AG048270
Secondary ID 1U01AG048270-01
Status Completed
Phase Phase 3
First received
Last updated
Start date August 2015
Est. completion date January 2020

Study information

Verified date March 2021
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this pragmatic cluster-randomized trial is to determine the effectiveness of an evidence-based, patient-centered multifactorial fall injury prevention strategy in community dwelling older adults at risk of falls recruited from 86 primary care practices around the U.S.


Description:

Objective: To determine the effectiveness of an evidence-based, patient-centered multifactorial fall injury prevention strategy implemented within primary care practices using usual health care resources Design: This study is a cluster randomized, parallel group superiority trial with practices stratified by healthcare system and patients nested within practices. The unit of randomization is the practice. Study Duration: The total study duration is 5 years. Recruitment will take place over 20 months, with follow-up taking place for 24 months - 44 months depending on date of enrollment. Trial Sites: 86 primary care practices that are part of 10 trial sites located around the U.S.: The Partners' Health Care System; Essentia; Hopkins Health Care System; HealthCare Partners; Reliant Health Care System; Mount Sinai Health Care System; University of Pittsburgh Health Care System; University of Texas Medical Branch Health Care System; University of Iowa Health Care System; University of Michigan Health Care System. Number of Subjects: The original target sample size was 6,000 participants enrolled in 86 practices to provide 90% power to detect a 20% reduction in the rate of the primary outcome with intervention relative to control. The study was originally designed for a study duration of 36 months with 18 months of recruitment and a minimum of 18 months of follow-up. The study was extended to a 44 month study (20 months of recruitment and a minimum 24 month of follow-up). For a 44 month trial, it was estimated that a sample size of 5,322 subjects would provide 90% power to detect a 20% reduction in the rate of the primary outcome with the intervention relative to control. Main Inclusion Criteria Community-living persons, 70 years or older, who are at increased risk for serious fall injuries. Intervention: An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the Center for Disease Control's (CDC's) "STEADI" toolbox (Stopping Elderly Accidents, Disability and Injury) and the joint American Geriatrics Society/British Geriatrics Society guidelines, and Assessing Care of Vulnerable Elders (ACOVE) practice change approach. The fall prevention strategies will be systematically implemented into clinical practice using: delivery system design to improve quality (Co-management); decision support (algorithms); information systems (software); self-management support (patient/caregiver engagement and activation); and linkage to community-based resources. Primary Outcome: The primary outcome is adjudicated serious fall injuries, operationalized as a fall resulting in: (1) (fracture other than thoracic/lumbar vertebral; joint dislocation; or cut requiring closure) AND any medical attention; OR (2) (head injury; sprain or strain; bruising or swelling; or other) requiring hospitalization. Primary Analysis: The risk of any serious fall injury (i.e., time to first event) will be analyzed using a survival model that incorporates competing risks (due to death) and clustering. In this analysis, participants who are lost to follow-up without a prior serious fall-related injury will be censored at their date last seen. In a sensitivity analysis, the investigators will adjust for the pre-specified set of baseline covariates to examine their influence on the intervention effect. Secondary Outcomes: All self-reported falls, all self-reported fall-related injuries, and measures of well-being.


Recruitment information / eligibility

Status Completed
Enrollment 5451
Est. completion date January 2020
Est. primary completion date December 2019
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria: - The patient is at least 70 years of age. - The patient must answer 'yes' to one or more of the following questions: - Have you fallen and hurt yourself in the past year? - Have you fallen 2 or more times in the past year? - Are you afraid that you might fall because of balance or walking problems? Exclusion Criteria: - The patient is enrolled in hospice. - The patient resides in a nursing home. - The patient is not capable of providing informed consent (or assent), and a proxy is not available. - The patient does not speak English or Spanish

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Evidence-based tailored fall prevention

Usual care


Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan
United States Johns Hopkins Medicine Baltimore Maryland
United States Partners Healthcare Boston Massachusetts
United States University of Iowa Health Alliance Des Moines Iowa
United States Essentia Health Duluth Minnesota
United States University of Texas Medical Branch at Galveston Galveston Texas
United States Mt Sinai Health System New York New York
United States University of Pittsburgh Pittsburgh Pennsylvania
United States Healthcare Partners Torrance California
United States Reliant Medical Group Worcester Massachusetts

Sponsors (17)

Lead Sponsor Collaborator
Brigham and Women's Hospital Essentia Health, Healthcare Partners, Johns Hopkins University, Mt Sinai Health System, National Institute on Aging (NIA), National Institutes of Health (NIH), Partners HealthCare, Patient-Centered Outcomes Research Institute, Reliant Medical Group, The University of Texas Medical Branch, Galveston, University of California, Los Angeles, University of Iowa Health Alliance, University of Michigan, University of Pittsburgh Medical Center, Wake Forest University, Yale University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary First Adjudicated Serious Fall-Related Injury Number of first adjudicated serious fall-related injury serious fall-related injury events per 100 per years of follow-up. Enrollment through last completed follow-up or death interview (max 44 months)
Secondary First Self-reported Fall-related Injury Number of first self-reported fall-related injuries per 100 per years of follow-up Enrollment through last completed follow-up or death interview (max 44 months)
Secondary Time to Self-reported Falls ** data for this outcome was not collected these data were not collected
Secondary Physical Function Late Life Function and Disability Instrument (LL-FDI) function score. The scores are on a 0-100 scale, higher score = better function. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores
Secondary Disability Late Life Function and Disability Instrument (LL-FDI) disability score. The scores are on a 0-100 scale, higher score = less disability. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores
Secondary Anxiety Patient-reported Outcome Measure Information System (PROMIS) Anxiety subscale. Measured on a 8-40 Scale, higher score = more anxiety. Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.
Secondary Depression PROMIS depression subscale. Measured on a 8-40 Scale, higher score = more depression. Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.
Secondary Fear of Falling Falls Efficacy Scale. Measured on a 10-40 Scale, higher score = more fear of falling. Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.
See also
  Status Clinical Trial Phase
Recruiting NCT04554212 - Blood Flow Restriction Training After Patellar INStability N/A
Suspended NCT02932176 - Machine Learning for Handheld Vascular Studies
Recruiting NCT04803253 - Study of the Social and Professional Reintegration Improvements Using a Set of Solutions for Upper Limb Amputation N/A
Completed NCT00116337 - Spinal Cord Stimulation to Restore Cough N/A
Completed NCT03463720 - Outcome for Patients With War-Associated Extremity Wound Infection N/A
Completed NCT03113253 - TRANexamic Acid to Reduce Bleeding in BURN Surgery Phase 4
Not yet recruiting NCT05492903 - COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP) N/A
Terminated NCT02909231 - One-year Patient Reported Outcomes Following Hospitalization for Trauma N/A
Completed NCT02432456 - Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients Phase 4
Completed NCT02744144 - Wound Bacterial Microbiota and Their Antibiotic Resistance N/A
Completed NCT02266771 - Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice N/A
Completed NCT02394821 - Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide Phase 3
Not yet recruiting NCT01665963 - Efficacy of TopClosure(C)System in Healing Complicated Pacemaker Wounds N/A
Completed NCT00151112 - Comparison of Two Different Procedures for Plexus Anesthesia N/A
Not yet recruiting NCT03872544 - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Recruiting NCT04596124 - Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze N/A
Recruiting NCT05800834 - Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds Phase 2
Enrolling by invitation NCT03880188 - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Terminated NCT04775316 - Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing
Enrolling by invitation NCT03312504 - Implementing a School Prevention Program to Reduce Injuries Through Neuromuscular Training N/A